Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_37399410_37399606 | MEIS2 | 6004 | 0.237617 | 0.72 | 3.0e-02 | Click! |
chr15_37385721_37385872 | MEIS2 | 970 | 0.598785 | 0.66 | 5.5e-02 | Click! |
chr15_37396233_37396384 | MEIS2 | 2804 | 0.295318 | 0.61 | 8.1e-02 | Click! |
chr15_37385423_37385574 | MEIS2 | 1268 | 0.498180 | 0.58 | 9.8e-02 | Click! |
chr15_37399056_37399207 | MEIS2 | 5627 | 0.240027 | 0.51 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_38412223_38412952 | 1.83 |
INPP5B |
inositol polyphosphate-5-phosphatase, 75kDa |
136 |
0.94 |
chr10_102278895_102279852 | 1.82 |
SEC31B |
SEC31 homolog B (S. cerevisiae) |
218 |
0.92 |
chr11_63273553_63274069 | 1.65 |
LGALS12 |
lectin, galactoside-binding, soluble, 12 |
24 |
0.97 |
chr1_4999527_4999744 | 1.60 |
AJAP1 |
adherens junctions associated protein 1 |
284530 |
0.01 |
chr11_6676307_6676669 | 1.51 |
DCHS1 |
dachsous cadherin-related 1 |
597 |
0.56 |
chr6_112555463_112555614 | 1.31 |
RP11-506B6.6 |
|
1756 |
0.35 |
chr19_10678474_10679697 | 1.28 |
CDKN2D |
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
569 |
0.54 |
chr11_65058660_65059302 | 1.25 |
POLA2 |
polymerase (DNA directed), alpha 2, accessory subunit |
9003 |
0.12 |
chr18_73496416_73496569 | 1.22 |
SMIM21 |
small integral membrane protein 21 |
356834 |
0.01 |
chr12_32702560_32702945 | 1.21 |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
15494 |
0.25 |
chrX_3629951_3631442 | 1.18 |
PRKX |
protein kinase, X-linked |
953 |
0.63 |
chr16_739557_740625 | 1.16 |
WDR24 |
WD repeat domain 24 |
309 |
0.55 |
chr6_19465542_19465832 | 1.14 |
ENSG00000201523 |
. |
27173 |
0.27 |
chr12_131364699_131365309 | 1.14 |
RAN |
RAN, member RAS oncogene family |
8363 |
0.16 |
chr12_57527559_57527864 | 1.14 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
1789 |
0.2 |
chr3_87036535_87037613 | 1.10 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr8_42063953_42065062 | 1.09 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr2_210444017_210444208 | 1.07 |
MAP2 |
microtubule-associated protein 2 |
33 |
0.99 |
chr4_148079475_148079775 | 1.07 |
ENSG00000221369 |
. |
186244 |
0.03 |
chr14_24837426_24838101 | 1.06 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
216 |
0.85 |
chr15_65578383_65579365 | 1.04 |
PARP16 |
poly (ADP-ribose) polymerase family, member 16 |
307 |
0.76 |
chr2_100879260_100879435 | 1.04 |
LONRF2 |
LON peptidase N-terminal domain and ring finger 2 |
46620 |
0.16 |
chr4_152146952_152147499 | 1.04 |
SH3D19 |
SH3 domain containing 19 |
7 |
0.98 |
chr19_19174720_19175940 | 1.03 |
SLC25A42 |
solute carrier family 25, member 42 |
522 |
0.7 |
chr2_200446222_200446758 | 1.03 |
SATB2 |
SATB homeobox 2 |
110501 |
0.07 |
chr18_57326676_57327097 | 1.00 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
6508 |
0.21 |
chr12_117036919_117037510 | 1.00 |
MAP1LC3B2 |
microtubule-associated protein 1 light chain 3 beta 2 |
23558 |
0.24 |
chrX_65857892_65858837 | 0.98 |
EDA2R |
ectodysplasin A2 receptor |
519 |
0.86 |
chr15_73263869_73264224 | 0.98 |
NEO1 |
neogenin 1 |
80005 |
0.1 |
chr1_78356045_78356196 | 0.98 |
NEXN-AS1 |
NEXN antisense RNA 1 |
896 |
0.52 |
chr1_225654970_225655492 | 0.97 |
RP11-496N12.6 |
|
2186 |
0.34 |
chr10_103113937_103114913 | 0.97 |
BTRC |
beta-transducin repeat containing E3 ubiquitin protein ligase |
134 |
0.95 |
chr9_91792568_91792943 | 0.97 |
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
927 |
0.67 |
chr6_144471049_144472508 | 0.97 |
STX11 |
syntaxin 11 |
115 |
0.98 |
chr20_30457693_30458808 | 0.97 |
DUSP15 |
dual specificity phosphatase 15 |
125 |
0.67 |
chr12_75876585_75876939 | 0.97 |
GLIPR1 |
GLI pathogenesis-related 1 |
1778 |
0.34 |
chr5_151065179_151065606 | 0.96 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
601 |
0.67 |
chr1_224805949_224806359 | 0.95 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
2159 |
0.29 |
chr17_16318840_16319577 | 0.95 |
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
282 |
0.77 |
chr5_111090218_111090459 | 0.95 |
NREP |
neuronal regeneration related protein |
1610 |
0.42 |
chr17_38128484_38128998 | 0.94 |
GSDMA |
gasdermin A |
6965 |
0.12 |
chr11_67168049_67169301 | 0.93 |
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme |
584 |
0.47 |
chr20_53239107_53239289 | 0.92 |
DOK5 |
docking protein 5 |
146941 |
0.05 |
chr6_136360177_136360429 | 0.91 |
RP13-143G15.3 |
|
25473 |
0.21 |
chr10_73498248_73498460 | 0.90 |
C10orf105 |
chromosome 10 open reading frame 105 |
773 |
0.68 |
chr5_36300727_36300926 | 0.90 |
RANBP3L |
RAN binding protein 3-like |
1176 |
0.55 |
chr9_139837883_139838667 | 0.90 |
FBXW5 |
F-box and WD repeat domain containing 5 |
711 |
0.36 |
chr8_9005417_9005811 | 0.90 |
PPP1R3B |
protein phosphatase 1, regulatory subunit 3B |
2592 |
0.23 |
chr4_72132010_72132365 | 0.89 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
72583 |
0.13 |
chrX_40004759_40006118 | 0.89 |
BCOR |
BCL6 corepressor |
444 |
0.9 |
chr21_36800750_36801029 | 0.89 |
ENSG00000211590 |
. |
292124 |
0.01 |
chr7_6296015_6296815 | 0.88 |
CYTH3 |
cytohesin 3 |
15860 |
0.17 |
chr1_9256722_9257085 | 0.88 |
H6PD |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
37931 |
0.13 |
chr20_13329495_13329726 | 0.88 |
RP5-1077I2.3 |
|
103594 |
0.07 |
chr16_64927185_64927365 | 0.88 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
166306 |
0.04 |
chr15_100052430_100052643 | 0.87 |
AC015660.1 |
HCG1993240; Serologically defined breast cancer antigen NY-BR-40; Uncharacterized protein |
13958 |
0.21 |
chrY_15398432_15398730 | 0.87 |
AC010877.1 |
Uncharacterized protein |
19886 |
0.28 |
chr5_14442202_14442353 | 0.87 |
TRIO |
trio Rho guanine nucleotide exchange factor |
46280 |
0.19 |
chr2_240240902_240241261 | 0.87 |
HDAC4 |
histone deacetylase 4 |
10174 |
0.18 |
chr8_13372225_13372384 | 0.87 |
DLC1 |
deleted in liver cancer 1 |
30 |
0.98 |
chrX_114467670_114468385 | 0.86 |
LRCH2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
601 |
0.77 |
chr12_49390557_49391281 | 0.86 |
RP11-386G11.5 |
|
1231 |
0.19 |
chr5_92918344_92919004 | 0.86 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
369 |
0.84 |
chr1_1207989_1209115 | 0.86 |
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2 |
299 |
0.76 |
chr6_116479760_116479954 | 0.86 |
COL10A1 |
collagen, type X, alpha 1 |
53 |
0.98 |
chr12_72667295_72667865 | 0.86 |
TRHDE |
thyrotropin-releasing hormone degrading enzyme |
317 |
0.85 |
chr2_65578222_65578373 | 0.86 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
6377 |
0.25 |
chr9_18476779_18476930 | 0.86 |
ADAMTSL1 |
ADAMTS-like 1 |
2623 |
0.41 |
chr15_23931247_23932124 | 0.85 |
NDN |
necdin, melanoma antigen (MAGE) family member |
765 |
0.7 |
chr11_60906888_60907039 | 0.85 |
VPS37C |
vacuolar protein sorting 37 homolog C (S. cerevisiae) |
21645 |
0.14 |
chr7_944726_944918 | 0.84 |
ADAP1 |
ArfGAP with dual PH domains 1 |
108 |
0.96 |
chr2_66735772_66735923 | 0.84 |
MEIS1 |
Meis homeobox 1 |
212 |
0.96 |
chr3_114170562_114171054 | 0.84 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
2722 |
0.36 |
chr1_86713350_86713501 | 0.84 |
COL24A1 |
collagen, type XXIV, alpha 1 |
90799 |
0.09 |
chr2_110657178_110657382 | 0.83 |
LIMS3 |
LIM and senescent cell antigen-like domains 3 |
1012 |
0.67 |
chr10_22894404_22894761 | 0.83 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
13940 |
0.29 |
chr6_56555918_56556226 | 0.83 |
DST |
dystonin |
48278 |
0.18 |
chr3_130646596_130646747 | 0.83 |
RP11-39E3.3 |
|
2149 |
0.25 |
chr17_63590380_63590998 | 0.83 |
AXIN2 |
axin 2 |
32924 |
0.2 |
chrX_118372355_118372574 | 0.83 |
PGRMC1 |
progesterone receptor membrane component 1 |
2176 |
0.39 |
chr1_67000815_67001114 | 0.83 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
999 |
0.67 |
chr6_85823864_85824548 | 0.82 |
NT5E |
5'-nucleotidase, ecto (CD73) |
335603 |
0.01 |
chr7_111721329_111721542 | 0.82 |
DOCK4 |
dedicator of cytokinesis 4 |
77249 |
0.11 |
chr2_8818889_8820001 | 0.81 |
AC011747.7 |
|
259 |
0.7 |
chr10_105419847_105420526 | 0.81 |
SH3PXD2A |
SH3 and PX domains 2A |
1276 |
0.44 |
chr7_64895070_64895221 | 0.81 |
ZNF92 |
zinc finger protein 92 |
56351 |
0.13 |
chr17_80817564_80818630 | 0.80 |
TBCD |
tubulin folding cofactor D |
173 |
0.94 |
chr1_225838101_225838290 | 0.80 |
ENAH |
enabled homolog (Drosophila) |
2223 |
0.33 |
chr6_73095984_73096135 | 0.80 |
RIMS1 |
regulating synaptic membrane exocytosis 1 |
19627 |
0.28 |
chr9_90588787_90589959 | 0.80 |
CDK20 |
cyclin-dependent kinase 20 |
29 |
0.98 |
chr19_18451078_18452116 | 0.80 |
PGPEP1 |
pyroglutamyl-peptidase I |
148 |
0.91 |
chr9_95007612_95008037 | 0.80 |
IARS |
isoleucyl-tRNA synthetase |
441 |
0.83 |
chr18_46459073_46459525 | 0.80 |
SMAD7 |
SMAD family member 7 |
15576 |
0.24 |
chr7_128471351_128471889 | 0.79 |
FLNC |
filamin C, gamma |
1140 |
0.39 |
chr17_29335129_29336577 | 0.79 |
RP11-848P1.9 |
|
81 |
0.95 |
chr12_32261770_32262117 | 0.79 |
RP11-843B15.2 |
|
1481 |
0.38 |
chr8_82771057_82771404 | 0.79 |
SNX16 |
sorting nexin 16 |
16129 |
0.24 |
chr6_19838575_19839711 | 0.79 |
RP1-167F1.2 |
|
168 |
0.95 |
chr13_24007498_24007984 | 0.79 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
100 |
0.98 |
chr5_135330421_135330572 | 0.78 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
34088 |
0.15 |
chr5_67294562_67294875 | 0.78 |
ENSG00000223149 |
. |
31445 |
0.24 |
chr4_26577939_26578090 | 0.78 |
TBC1D19 |
TBC1 domain family, member 19 |
45 |
0.98 |
chr1_67001120_67001322 | 0.78 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
1256 |
0.58 |
chr10_27148230_27149879 | 0.77 |
ABI1 |
abl-interactor 1 |
738 |
0.67 |
chr15_64231749_64232239 | 0.77 |
RP11-111E14.1 |
|
11521 |
0.22 |
chr4_151509067_151509271 | 0.77 |
MAB21L2 |
mab-21-like 2 (C. elegans) |
6092 |
0.23 |
chr10_88159807_88161210 | 0.77 |
GRID1 |
glutamate receptor, ionotropic, delta 1 |
34273 |
0.17 |
chr6_133240232_133240530 | 0.77 |
ENSG00000200534 |
. |
102023 |
0.06 |
chr3_25470006_25470271 | 0.77 |
RARB |
retinoic acid receptor, beta |
336 |
0.93 |
chr1_244012088_244013269 | 0.76 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
752 |
0.75 |
chr10_110672045_110672364 | 0.76 |
ENSG00000222436 |
. |
28864 |
0.27 |
chr16_70221940_70222878 | 0.76 |
CLEC18C |
C-type lectin domain family 18, member C |
14349 |
0.1 |
chr2_226029504_226029655 | 0.76 |
DOCK10 |
dedicator of cytokinesis 10 |
122420 |
0.06 |
chr1_95389567_95389941 | 0.76 |
CNN3 |
calponin 3, acidic |
1583 |
0.36 |
chr5_151076497_151076648 | 0.76 |
ENSG00000222102 |
. |
7567 |
0.15 |
chr5_155903124_155903466 | 0.76 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
149528 |
0.04 |
chr2_239752907_239753200 | 0.76 |
TWIST2 |
twist family bHLH transcription factor 2 |
3620 |
0.32 |
chr22_27040814_27041099 | 0.76 |
CRYBA4 |
crystallin, beta A4 |
23028 |
0.17 |
chr5_169406404_169406555 | 0.76 |
FAM196B |
family with sequence similarity 196, member B |
1265 |
0.56 |
chr10_30346435_30346778 | 0.76 |
KIAA1462 |
KIAA1462 |
1847 |
0.5 |
chr12_2163640_2163867 | 0.75 |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
1024 |
0.49 |
chr1_12290222_12291451 | 0.75 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
712 |
0.66 |
chr10_112445044_112445195 | 0.75 |
RBM20 |
RNA binding motif protein 20 |
40964 |
0.12 |
chr3_129323468_129324020 | 0.75 |
PLXND1 |
plexin D1 |
1917 |
0.3 |
chr7_95401616_95402462 | 0.75 |
DYNC1I1 |
dynein, cytoplasmic 1, intermediate chain 1 |
123 |
0.98 |
chr13_21654027_21654296 | 0.75 |
LATS2 |
large tumor suppressor kinase 2 |
18475 |
0.14 |
chr8_28256571_28256722 | 0.74 |
ZNF395 |
zinc finger protein 395 |
3572 |
0.17 |
chr18_53251476_53251684 | 0.74 |
TCF4 |
transcription factor 4 |
1088 |
0.65 |
chrX_153199314_153200499 | 0.74 |
NAA10 |
N(alpha)-acetyltransferase 10, NatA catalytic subunit |
505 |
0.6 |
chr6_35016267_35016533 | 0.74 |
TCP11 |
t-complex 11, testis-specific |
72422 |
0.1 |
chr6_9646750_9646901 | 0.74 |
OFCC1 |
orofacial cleft 1 candidate 1 |
286675 |
0.01 |
chr11_34272575_34273299 | 0.74 |
ENSG00000201867 |
. |
62216 |
0.13 |
chr4_138451326_138451477 | 0.74 |
PCDH18 |
protocadherin 18 |
2164 |
0.49 |
chr6_117852473_117852851 | 0.74 |
DCBLD1 |
discoidin, CUB and LCCL domain containing 1 |
48837 |
0.12 |
chr15_89454191_89454687 | 0.74 |
MFGE8 |
milk fat globule-EGF factor 8 protein |
2154 |
0.3 |
chr11_35035790_35035960 | 0.74 |
PDHX |
pyruvate dehydrogenase complex, component X |
36544 |
0.17 |
chr16_1875831_1876591 | 0.74 |
HAGH |
hydroxyacylglutathione hydrolase |
568 |
0.4 |
chr15_55581400_55582110 | 0.74 |
RAB27A |
RAB27A, member RAS oncogene family |
246 |
0.92 |
chr14_25512019_25512227 | 0.74 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
6083 |
0.33 |
chr1_247611615_247612128 | 0.74 |
OR2B11 |
olfactory receptor, family 2, subfamily B, member 11 |
3437 |
0.2 |
chr10_74262535_74262792 | 0.74 |
RP11-167P22.3 |
|
1159 |
0.49 |
chr5_52132959_52133110 | 0.73 |
CTD-2288O8.1 |
|
49174 |
0.13 |
chr3_46448557_46448708 | 0.73 |
CCRL2 |
chemokine (C-C motif) receptor-like 2 |
22 |
0.55 |
chr8_34940612_34940763 | 0.73 |
ENSG00000265560 |
. |
112963 |
0.07 |
chr3_117118590_117118770 | 0.73 |
ENSG00000206889 |
. |
144372 |
0.05 |
chr1_66999832_67000057 | 0.73 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
21 |
0.99 |
chr5_14983876_14984027 | 0.73 |
ENSG00000212036 |
. |
73202 |
0.11 |
chr2_38055406_38055705 | 0.73 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
89944 |
0.08 |
chr2_109272345_109272703 | 0.73 |
LIMS1 |
LIM and senescent cell antigen-like domains 1 |
1015 |
0.59 |
chr11_8040357_8041136 | 0.73 |
TUB |
tubby bipartite transcription factor |
45 |
0.96 |
chr22_19702276_19702683 | 0.73 |
SEPT5 |
septin 5 |
281 |
0.9 |
chr3_157156849_157157000 | 0.73 |
PTX3 |
pentraxin 3, long |
2346 |
0.38 |
chr10_104470168_104470319 | 0.72 |
ARL3 |
ADP-ribosylation factor-like 3 |
3921 |
0.18 |
chr13_36273754_36273977 | 0.72 |
NBEA |
neurobeachin |
106722 |
0.07 |
chr16_74440490_74441404 | 0.72 |
CLEC18B |
C-type lectin domain family 18, member B |
14343 |
0.14 |
chr9_16267382_16267618 | 0.72 |
C9orf92 |
chromosome 9 open reading frame 92 |
8811 |
0.32 |
chr2_33359781_33360142 | 0.72 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
237 |
0.96 |
chr16_58529357_58529558 | 0.72 |
ENSG00000200556 |
. |
1355 |
0.33 |
chr11_117185897_117186711 | 0.72 |
BACE1 |
beta-site APP-cleaving enzyme 1 |
210 |
0.87 |
chr5_42756888_42757786 | 0.72 |
CCDC152 |
coiled-coil domain containing 152 |
417 |
0.88 |
chr2_216288358_216288696 | 0.72 |
FN1 |
fibronectin 1 |
12263 |
0.21 |
chr9_117149358_117150269 | 0.71 |
AKNA |
AT-hook transcription factor |
430 |
0.85 |
chr22_50944990_50945511 | 0.71 |
LMF2 |
lipase maturation factor 2 |
863 |
0.3 |
chr6_7592057_7592208 | 0.71 |
SNRNP48 |
small nuclear ribonucleoprotein 48kDa (U11/U12) |
1700 |
0.43 |
chr15_78202944_78203127 | 0.71 |
ENSG00000242066 |
. |
6289 |
0.14 |
chr7_23051125_23051427 | 0.71 |
FAM126A |
family with sequence similarity 126, member A |
2417 |
0.38 |
chr2_70332039_70332202 | 0.71 |
PCBP1-AS1 |
PCBP1 antisense RNA 1 |
16142 |
0.15 |
chr19_56915770_56916270 | 0.71 |
ZNF583 |
zinc finger protein 583 |
302 |
0.8 |
chr19_45254003_45254720 | 0.71 |
BCL3 |
B-cell CLL/lymphoma 3 |
217 |
0.88 |
chr2_237572334_237572577 | 0.71 |
ACKR3 |
atypical chemokine receptor 3 |
94171 |
0.09 |
chr8_23618854_23619099 | 0.71 |
ENSG00000216123 |
. |
7182 |
0.19 |
chr17_67137803_67138011 | 0.71 |
ABCA6 |
ATP-binding cassette, sub-family A (ABC1), member 6 |
108 |
0.97 |
chr11_85429273_85429899 | 0.71 |
SYTL2 |
synaptotagmin-like 2 |
55 |
0.97 |
chr16_66041872_66042044 | 0.71 |
ENSG00000201999 |
. |
293754 |
0.01 |
chr5_9698511_9698662 | 0.70 |
TAS2R1 |
taste receptor, type 2, member 1 |
13726 |
0.22 |
chr4_160188472_160188729 | 0.70 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
287 |
0.93 |
chr18_61974366_61974517 | 0.70 |
ENSG00000252818 |
. |
242301 |
0.02 |
chr3_53840282_53840557 | 0.70 |
RP11-884K10.6 |
|
8373 |
0.15 |
chr9_91849736_91849943 | 0.70 |
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
56157 |
0.12 |
chr1_226242002_226242153 | 0.70 |
H3F3A |
H3 histone, family 3A |
7475 |
0.17 |
chr1_46330011_46330183 | 0.70 |
MAST2 |
microtubule associated serine/threonine kinase 2 |
49163 |
0.15 |
chr1_68258421_68258776 | 0.70 |
ENSG00000238778 |
. |
20262 |
0.19 |
chr3_184934142_184934696 | 0.70 |
ENSG00000264614 |
. |
36641 |
0.14 |
chr15_67021750_67022170 | 0.70 |
SMAD6 |
SMAD family member 6 |
17925 |
0.24 |
chr4_173978999_173979247 | 0.70 |
ENSG00000241652 |
. |
83671 |
0.09 |
chr7_66532196_66532424 | 0.70 |
ENSG00000266525 |
. |
47074 |
0.12 |
chr10_134388453_134389007 | 0.70 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
32700 |
0.18 |
chr9_136844272_136844460 | 0.69 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
13037 |
0.2 |
chr13_108520152_108520684 | 0.69 |
FAM155A |
family with sequence similarity 155, member A |
1335 |
0.55 |
chr4_39482632_39482783 | 0.69 |
LIAS |
lipoic acid synthetase |
22015 |
0.12 |
chr10_60778966_60779198 | 0.69 |
ENSG00000252076 |
. |
150138 |
0.04 |
chr18_56247055_56247246 | 0.69 |
ENSG00000252284 |
. |
20713 |
0.14 |
chr12_12961145_12961613 | 0.69 |
DDX47 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 |
4871 |
0.18 |
chr1_155989724_155990416 | 0.69 |
SSR2 |
signal sequence receptor, beta (translocon-associated protein beta) |
510 |
0.62 |
chr10_115032925_115033406 | 0.69 |
ENSG00000238380 |
. |
80019 |
0.11 |
chr18_12656814_12657797 | 0.69 |
SPIRE1 |
spire-type actin nucleation factor 1 |
570 |
0.5 |
chr6_157297379_157297598 | 0.69 |
ARID1B |
AT rich interactive domain 1B (SWI1-like) |
74981 |
0.12 |
chr2_139466433_139466584 | 0.69 |
NXPH2 |
neurexophilin 2 |
71410 |
0.13 |
chr2_66666437_66666864 | 0.68 |
MEIS1 |
Meis homeobox 1 |
197 |
0.85 |
chr13_29080015_29080166 | 0.68 |
FLT1 |
fms-related tyrosine kinase 1 |
10825 |
0.29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.7 | 2.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.7 | 2.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.6 | 2.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 1.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 1.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 1.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 3.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 1.3 | GO:0052257 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.4 | 2.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.4 | 0.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.4 | 1.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.4 | 1.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.8 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.4 | 1.5 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.4 | 0.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 1.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.3 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.3 | 1.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 1.2 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.3 | 0.6 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 2.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 0.9 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.3 | 0.6 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.3 | 1.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.9 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 1.1 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.3 | 0.6 | GO:0001660 | fever generation(GO:0001660) |
0.3 | 1.6 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.3 | 0.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 0.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.8 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.3 | 1.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.9 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.2 | 1.4 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.2 | 0.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 0.7 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 1.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.4 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.2 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.2 | 0.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.9 | GO:0031641 | regulation of myelination(GO:0031641) |
0.2 | 0.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.6 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 0.4 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 1.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 1.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 1.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.4 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 1.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.2 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.9 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 1.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 1.4 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.2 | 0.4 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.2 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 1.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.9 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.7 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 3.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 0.5 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.2 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.2 | 0.6 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.9 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 0.8 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 0.6 | GO:0010800 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 3.5 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 0.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.9 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 1.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.4 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.1 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.8 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.4 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.4 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.1 | 0.4 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.1 | 0.3 | GO:0010470 | endodermal cell fate specification(GO:0001714) regulation of gastrulation(GO:0010470) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 1.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.4 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.5 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.4 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.1 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.7 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.1 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.6 | GO:0070168 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.9 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.5 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.5 | GO:2000258 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.1 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.6 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 1.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.6 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0070431 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.4 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.3 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.8 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 1.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.2 | GO:0034391 | positive regulation of muscle cell apoptotic process(GO:0010661) smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.5 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.3 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 2.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.2 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.7 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.2 | GO:2000696 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.4 | GO:0050795 | regulation of behavior(GO:0050795) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 1.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 2.2 | GO:0051318 | G1 phase(GO:0051318) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.3 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 4.4 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.4 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of calcium ion transmembrane transporter activity(GO:1901021) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) positive regulation of cation channel activity(GO:2001259) |
0.1 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.4 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.6 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.6 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.2 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.1 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.8 | GO:0051668 | localization within membrane(GO:0051668) |
0.1 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.3 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.1 | 0.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 1.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.2 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.1 | GO:0052552 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0070933 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.2 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 0.2 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.1 | 0.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.6 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.6 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.2 | GO:1904064 | positive regulation of cation transmembrane transport(GO:1904064) |
0.1 | 0.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.3 | GO:0010171 | body morphogenesis(GO:0010171) |
0.1 | 1.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 1.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0032692 | negative regulation of interleukin-1 beta production(GO:0032691) negative regulation of interleukin-1 production(GO:0032692) |
0.1 | 0.6 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.1 | GO:0031935 | regulation of chromatin silencing(GO:0031935) negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.1 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.1 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.1 | 0.1 | GO:0033604 | regulation of epinephrine secretion(GO:0014060) negative regulation of catecholamine secretion(GO:0033604) negative regulation of amine transport(GO:0051953) |
0.1 | 0.2 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.2 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 1.0 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:2000756 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.2 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.3 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.0 | 0.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.2 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 1.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.0 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 1.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.3 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 1.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.2 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0060298 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.4 | GO:1902579 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.2 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.0 | GO:0002369 | T cell cytokine production(GO:0002369) regulation of T cell cytokine production(GO:0002724) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.2 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.4 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.5 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.9 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.0 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.0 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.0 | 0.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.4 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.2 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.2 | GO:0006949 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.6 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.0 | GO:0051771 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.0 | GO:0032634 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.3 | GO:0045143 | synapsis(GO:0007129) homologous chromosome segregation(GO:0045143) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 | 0.1 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.2 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.3 | GO:0022406 | membrane docking(GO:0022406) |
0.0 | 0.0 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0034764 | positive regulation of transmembrane transport(GO:0034764) positive regulation of ion transmembrane transport(GO:0034767) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.0 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.0 | GO:0014034 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 2.6 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.4 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0071696 | ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
0.0 | 0.3 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.0 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.4 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.3 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0007272 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0048892 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.3 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.4 | 0.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.4 | 4.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 2.0 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 2.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 1.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 2.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.0 | GO:0032059 | bleb(GO:0032059) |
0.2 | 1.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 1.4 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.7 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 0.5 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.2 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.5 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.4 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 3.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 3.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 2.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.7 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.5 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 3.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.6 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 1.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.1 | GO:0030313 | cell envelope(GO:0030313) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.7 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.0 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 11.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 2.5 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 3.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 5.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 1.9 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.9 | GO:0030055 | cell-substrate adherens junction(GO:0005924) cell-substrate junction(GO:0030055) |
0.0 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.9 | GO:0005929 | cilium(GO:0005929) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.7 | 2.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 1.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 1.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 1.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.5 | 3.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 1.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.3 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 2.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 1.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 1.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 1.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.2 | 0.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 2.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.2 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 2.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.6 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 3.3 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 5.6 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.2 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 2.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 2.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 2.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 2.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 5.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 4.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 2.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 1.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 2.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.2 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.3 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 1.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.0 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 3.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 1.2 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.3 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 1.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.9 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 4.5 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 1.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 1.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.2 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.4 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.9 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.6 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.0 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.6 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 5.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 6.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 10.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 7.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 2.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 5.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 2.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 5.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.1 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 3.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 2.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.9 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 1.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.4 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |